Lawyers and Settlements
Home Page >> Lawsuits Filed >> Lawsuit: Taxotere Hair Loss Lawsuit Filed

Taxotere Hair Loss Lawsuit Filed

Were you looking for Taxotere Permanent Hair Loss lawsuits?


Santa Clara, CA: Sanofi-Aventis is facing a defective product lawsuit alleging its cancer drug Taxotere (Docetaxel) causes hair loss. Filed by Erma Spann, the lawsuit claims Sanofi withheld important information from patients about the potential long-term side effects of Taxotere.

FREE CASE EVALUATION

Send your Taxotere Hair Loss claim to a lawyer who will review your claim at NO COST or obligation.Get Legal Help Now

Taxotere Hair Loss Lawsuit

Spann alleges she has experienced on-going and permanent hair loss after undergoing chemotherapy involving Taxotere following a right breast partial mastectomy in February 2005.

Spann further alleges that Sanofi-Aventis knew or should have known that, unlike other cancer drugs, Taxotere had a high risk of permanent baldness, known as alopecia. She asserts that rather than issuing warnings regarding the potential for hair loss Sanofi concealed the information, depriving her and other patients of the opportunity to decide whether the risk of permanent baldness was justified.

"Although women might accept the possibility of permanent baldness as a result of the use of Taxotere if no other product were available to treat their cancer, this was not the case,"Spann states in the complaint. "Before Defendants' wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere."

The lawsuit cites a study published in 2005, known as GEICAM 9805, that found nearly 10% of patients who took Taxotere suffered permanent hair loss. The manufacturers were aware of that study and of observations by a Denver-based oncologist in 2006, which found that more than 6% of his Taxotere patients suffered permanent hair loss.

"Despite Defendants' knowledge of the relevant findings from the GEICAM 9805 study, as well as reports from patients who had taken Taxotere and suffered from permanent disfiguring hair loss, Defendants failed to provide accurate information and proper warnings to physicians, healthcare providers, and patients in the United States, including Plaintiff, that patients who take Taxotere are at a significantly increased risk of suffering from permanent disfiguring hair loss,"the lawsuit states. "Instead, Defendants chose to withhold this information in the United States despite advising physicians, patients, and regulatory agencies in other countries, including the European Union and Canada, that Taxotere causes an increased risk of permanent disfiguring hair loss."

According to the lawsuit, Taxotere warnings continue to vaguely and misleadingly indicate that "hair generally grows back"after use of the drug.



Taxotere Hair Loss Legal Help

If you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on

TAXOTERE HAIR LOSS LEGAL ARTICLES AND INTERVIEWS

Taxotere Hair Loss Does Additional Harm to Breast Cancer Survivors
Taxotere Hair Loss Does Additional Harm to Breast Cancer Survivors
November 12, 2017
Washington, DC: It’s there – like a sub audible hum – underneath Sanofi-Aventis’s decision not to disclose the risk of permanent Taxotere hair loss. It will certainly be there, underpinning the drug manufacturer’s offers to settle the lawsuits according to National Trial Lawyers. The effort to minimize the harm that Taxotere alopecia does to breast cancer survivors, though rarely said aloud, goes a lot like this [READ MORE]

Court Order Means Potential Taxotere Plaintiffs Should Act ASAP
Court Order Means Potential Taxotere Plaintiffs Should Act ASAP
October 11, 2017
New Orleans, LA: On September 7, 2017, the judge overseeing the multidistrict Taxotere hair loss litigation (MDL) issued a pre-trial order that compels attorneys to submit information about all pending and anticipated Taxotere lawsuits. The goal is to bring as many plaintiffs as possible into any settlement reached [READ MORE]

Did Sanofi-Aventis Have a Duty to Warn Patients about Permanent Hair Loss?
Did Sanofi-Aventis Have a Duty to Warn Patients about Permanent Hair Loss?
September 12, 2017
Santa Clara, CA: As the litigation shakes out, that question is at the heart of Taxotere hair loss suits now pending in federal courts in Louisiana and other jurisdictions. But whether Sanofi-Aventis had a duty to warn patients is more complicated than it might appear. It requires courts to define what responsibility pharmaceutical companies have to the patients who look to them for a cure [READ MORE]



ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.